Article title: Intracardiac Thrombus in Children: The Fine Equilibrium Between the Risk and the Benefit
Authors: İbrahim İlker Çetin, Filiz Ekici, Sevim Ünal, Abdullah Kocabaş, Şanlıay şahin, Mutlu Uysal Yazıcı, and Ganime Ayar
Journal: Pediatric Hematology and Oncology
Bibliometrics: Published in Volume 31, Issue 5, pages 481–487
DOI: 10.3109/08880018.2014.919546
Publisher: Taylor & Francis Group, LLC
The publisher would like to make the following corrections to the article “Intracardiac Thrombus in Children: The Fine Equilibrium Between the Risk and the Benefit,” by İbrahim İlker Çetin, Filiz Ekici, Sevim Ünal, Abdullah Kocabaş, Şanlıay Şahin, Mutlu Uysal Yazıcı, and Ganime Ayar:
References 9 and 10 should be exchanged with the following result:
[9] Payne JH. Aspects of anticoagulation in children. Br J Haematol. 2010;150: 259–277.
[10] Atalay S, Akar N, Tutar HE, et al. 1691 G-A mutation in children with intracardiac thrombosis: a prospective study. Acta Paediatr. 2002;91:168–171.
p. 482: Reference [3] should be removed from the end of the following sentence: “The treatment approaches were thrombolytics [tissue plasminogen activator (t-PA), streptokinase, urokinase] and/or anticoagulants (classical/low molecular weight (LMW) heparin, warfarin) or rarely surgical thrombectomy.”
p. 485: Reference [6] should be removed, and reference [14] added to the end of the following sentence: “The high procoagulant activity (increased thrombin formation), low anticoagulant (antithrombin III) levels, and immature fibrinolytic system (low plasminogen level) increases thrombotic risk in infants, especially in prematures and with low-birthweights.”
p. 486: Reference [3] should be removed, and reference [13] added to the end of the following sentence: “The size of thrombus determines the duration of therapy. The large and dense thrombus requires more prolonged therapy as a rule.”